今开:14.84 | 昨收:14.68 |
最高:14.87 | 最低:14.705 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.739483496E9 |
产业链观察03-13 22:22
#药闻简讯# 2024年3月13日--商业阶段的生物制药公司$催化剂制药(CPRX)$ 今天宣布在美国商业推出AGAMREE®(vamorolone)口服混悬液40 mg/mL,用于治疗两岁及以上患者的杜氏肌营养不良症(“DMD”)。继 2023 年 10 月 26 日获得美国食品和药物管理局 (FDA) 的批准后,AGAMREE 现在可以...查看全文
Catalyst(CPRX)02-29 06:35
$催化剂制药(CPRX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-24-050908 Act: 34 Size: 10 MB 网页链接查看全文
Catalyst(CPRX)02-17 06:05
$催化剂制药(CPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001161697-24-000097 Size: 9 KB 网页链接查看全文
Catalyst(CPRX)02-17 06:05
$催化剂制药(CPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001161697-24-000104 Size: 7 KB 网页链接查看全文
Catalyst(CPRX)02-01 06:05
$催化剂制药(CPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001161697-24-000055 Size: 11 KB 网页链接查看全文
Catalyst(CPRX)04-09 02:05
$Catalyst(CPRX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002867 Act: 33 Size: 4 KB 网页链接查看全文
Catalyst(CPRX)03-28 03:05
$Catalyst(CPRX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002636 Act: 33 Size: 5 KB 网页链接查看全文
Catalyst(CPRX)03-14 05:05
$催化剂制药(CPRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-066931 Act: 34 Size: 172 KB 网页链接查看全文
Catalyst(CPRX)02-14 06:05
$催化剂制药(CPRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020550 Act: 34 Size: 13 KB 网页链接查看全文
Catalyst(CPRX)02-17 06:05
$催化剂制药(CPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001161697-24-000103 Size: 7 KB 网页链接查看全文
$Catalyst(CPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001161697-24-000194 Size: 9 KB 网页链接
$Catalyst(CPRX)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-091932 Act: 34 Size: 3 MB 网页链接
$Catalyst(CPRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-091926 Act: 34 Size: 2 MB 网页链接
$Catalyst(CPRX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002867 Act: 33 Size: 4 KB 网页链接
$Catalyst(CPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001161697-24-000164 Size: 5 KB 网页链接
$Catalyst(CPRX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002636 Act: 33 Size: 5 KB 网页链接
$催化剂制药(CPRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-066931 Act: 34 Size: 172 KB 网页链接
$催化剂制药(CPRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-051235 Act: 34 Size: 283 KB 网页链接
$催化剂制药(CPRX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-24-050908 Act: 34 Size: 10 MB 网页链接
$催化剂制药(CPRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-041520 Act: 34 Size: 170 KB 网页链接